Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

2.

Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials.

Graudal N, Hubeck-Graudal T, Tarp S, Christensen R, Jürgens G.

PLoS One. 2014 Sep 22;9(9):e106408. doi: 10.1371/journal.pone.0106408. eCollection 2014. Review.

3.

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.

Choy EH, Smith C, Doré CJ, Scott DL.

Rheumatology (Oxford). 2005 Nov;44(11):1414-21. Epub 2005 Jul 19. Review.

4.

A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis.

Ma MH, Kingsley GH, Scott DL.

Rheumatology (Oxford). 2010 Jan;49(1):91-8. doi: 10.1093/rheumatology/kep331. Epub 2009 Nov 16. Review.

5.

Have traditional DMARDs had their day? Effectiveness of parenteral gold compared to biologic agents.

Rau R.

Clin Rheumatol. 2005 Jun;24(3):189-202. Epub 2004 Jul 24. Review.

PMID:
15940552
6.

Effects of glucocorticoids on radiological progression in rheumatoid arthritis.

Kirwan JR, Bijlsma JW, Boers M, Shea BJ.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006356. Review.

PMID:
17253590
7.

[Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].

Yukawa N, Mimori T.

Clin Calcium. 2009 Mar;19(3):395-403. doi: CliCa0903395403. Review. Japanese.

PMID:
19252250
8.

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.

Gaujoux-Viala C, Nam J, Ramiro S, Landewé R, Buch MH, Smolen JS, Gossec L.

Ann Rheum Dis. 2014 Mar;73(3):510-5. doi: 10.1136/annrheumdis-2013-204588. Epub 2014 Jan 6. Review.

9.

Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis.

Katchamart W, Trudeau J, Phumethum V, Bombardier C.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008495. doi: 10.1002/14651858.CD008495. Review.

PMID:
20393970
10.

Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.

Singh JA, Cameron DR.

J Manag Care Pharm. 2012 May;18(4 Supp C):S1-18. Review.

PMID:
22656072
11.

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

Clark W, Jobanputra P, Barton P, Burls A.

Health Technol Assess. 2004 May;8(18):iii-iv, ix-x, 1-105. Review.

12.

Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.

Gaujoux-Viala C, Smolen JS, Landewé R, Dougados M, Kvien TK, Mola EM, Scholte-Voshaar M, van Riel P, Gossec L.

Ann Rheum Dis. 2010 Jun;69(6):1004-9. doi: 10.1136/ard.2009.127225. Epub 2010 May 6. Review.

PMID:
20447954
13.

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM.

Clin Ther. 2008 Nov;30(11):1939-55. doi: 10.1016/j.clinthera.2008.11.007. Review.

PMID:
19108784
14.
15.

The use of conventional disease-modifying anti-rheumatic drugs in established RA.

Jurgens MS, Jacobs JW, Bijlsma JW.

Best Pract Res Clin Rheumatol. 2011 Aug;25(4):523-33. doi: 10.1016/j.berh.2011.10.006. Review.

PMID:
22137922
16.

Drug therapy in undifferentiated arthritis: a systematic literature review.

Wevers-de Boer KV, Heimans L, Huizinga TW, Allaart CF.

Ann Rheum Dis. 2013 Sep 1;72(9):1436-44. doi: 10.1136/annrheumdis-2012-203165. Epub 2013 Jun 6. Review.

PMID:
23744979
17.

Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission.

Kuriya B, Arkema EV, Bykerk VP, Keystone EC.

Ann Rheum Dis. 2010 Jul;69(7):1298-304. doi: 10.1136/ard.2009.118307. Epub 2010 Apr 26. Review.

PMID:
20421343
18.

Methotrexate in rheumatoid arthritis.

Swierkot J, Szechiński J.

Pharmacol Rep. 2006 Jul-Aug;58(4):473-92. Review.

19.

The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials.

Lee YH, Bae SC, Song GG.

Rheumatol Int. 2011 Nov;31(11):1493-9. doi: 10.1007/s00296-010-1526-y. Epub 2010 May 16. Review.

PMID:
20473756
20.

Combination DMARD therapy including corticosteroids in early rheumatoid arthritis.

Möttönen TT, Hannonen PJ, Boers M.

Clin Exp Rheumatol. 1999 Nov-Dec;17(6 Suppl 18):S59-65. Review.

PMID:
10589359
Items per page

Supplemental Content

Write to the Help Desk